HYPD
NASDAQ · Pharmaceuticals
Hyperion Defi Inc
$3.27
-0.37 (-10.16%)
Financial Highlights (FY 2026)
Revenue
515.0K
Net Income
-447,700,612
Gross Margin
-6,749.0%
Profit Margin
-86,882.5%
Rev Growth
-84.0%
D/E Ratio
1.59
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | -6,749.0% | -6,749.0% | 34.6% | 34.6% |
| Operating Margin | -84,998.6% | -76,498.8% | 35.0% | 36.3% |
| Profit Margin | -86,882.5% | -82,538.4% | 29.2% | 24.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 515.0K | 3.22M | 5.01M | 5.20M |
| Gross Profit | -34,759,342 | -217,245,887 | 1.73M | 1.80M |
| Operating Income | -437,766,795 | -2,462,438,221 | 1.75M | 1.89M |
| Net Income | -447,700,612 | -2,518,315,942 | 1.46M | 1.25M |
| Gross Margin | -6,749.0% | -6,749.0% | 34.6% | 34.6% |
| Operating Margin | -84,998.6% | -76,498.8% | 35.0% | 36.3% |
| Profit Margin | -86,882.5% | -82,538.4% | 29.2% | 24.0% |
| Rev Growth | -84.0% | -84.0% | +22.0% | +7.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 8.20M | 8.20M | 11.29M | 13.39M |
| Total Equity | 5.16M | 5.16M | 25.06M | 25.22M |
| D/E Ratio | 1.59 | 1.59 | 0.45 | 0.53 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -428,666,262 | -2,545,205,930 | 1.99M | 2.29M |
| Free Cash Flow | — | — | 1.60M | 1.59M |